Fennec Pharmaceuticals Inc (FRX) NPV

Sell:0.00 CADBuy:14.00 CADPrice decreased0.21 CAD (1.53%)

Market closed |
Prices delayed by at least 15 minutes
Sell:0.00 CAD
Buy:14.00 CAD
Change:Price decreased0.21 CAD (1.53%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:0.00 CAD
Buy:14.00 CAD
Change:Price decreased0.21 CAD (1.53%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open13.98 CAD
Previous close13.71 CAD
Market capCA$458.16m
P/E ratio-
Volume2,135
Dividend yield0.00%
EMS-

Company information

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate, PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyCAD
  • Shares in issue34.74m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.